HUE057494T2 - Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására - Google Patents

Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására

Info

Publication number
HUE057494T2
HUE057494T2 HUE16828408A HUE16828408A HUE057494T2 HU E057494 T2 HUE057494 T2 HU E057494T2 HU E16828408 A HUE16828408 A HU E16828408A HU E16828408 A HUE16828408 A HU E16828408A HU E057494 T2 HUE057494 T2 HU E057494T2
Authority
HU
Hungary
Prior art keywords
skin
materials
methods
immune responses
barrier function
Prior art date
Application number
HUE16828408A
Other languages
English (en)
Inventor
Eva Berkes
Nicholas Monsul
Frederick T Boehm
Original Assignee
Quorum Innovations Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quorum Innovations Llc filed Critical Quorum Innovations Llc
Publication of HUE057494T2 publication Critical patent/HUE057494T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/143—Fermentum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Dermatology (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Plant Pathology (AREA)
  • Environmental Sciences (AREA)
  • Agronomy & Crop Science (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
HUE16828408A 2015-07-20 2016-07-19 Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására HUE057494T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201562194630P 2015-07-20 2015-07-20

Publications (1)

Publication Number Publication Date
HUE057494T2 true HUE057494T2 (hu) 2022-05-28

Family

ID=57835147

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE16828408A HUE057494T2 (hu) 2015-07-20 2016-07-19 Anyagok és eljárások immunválaszok és a bõr és/vagy nyálkahártya gátfunkciójának javítására

Country Status (18)

Country Link
US (5) US9706778B2 (hu)
EP (1) EP3324986B1 (hu)
JP (1) JP6727285B2 (hu)
KR (1) KR102258415B1 (hu)
CN (1) CN108135947B (hu)
AU (1) AU2016297539B9 (hu)
BR (1) BR112018001187B1 (hu)
CA (1) CA2991990C (hu)
DK (1) DK3324986T3 (hu)
ES (1) ES2904555T3 (hu)
HK (1) HK1253067A1 (hu)
HU (1) HUE057494T2 (hu)
IL (1) IL256973B (hu)
MX (1) MX2018000870A (hu)
PL (1) PL3324986T3 (hu)
PT (1) PT3324986T (hu)
WO (1) WO2017015275A1 (hu)
ZA (1) ZA201800209B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0811530B1 (pt) 2007-05-14 2019-01-02 Research Foundation Of State Univ Of New York composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
EP3324986B1 (en) * 2015-07-20 2021-11-24 Quorum Innovations, LLC Materials and methods for improving immune responses and the skin and/or mucosal barrier function
WO2018146550A1 (en) 2017-02-10 2018-08-16 De Maio Domingos Mauricio Methods and systems for preventing, correcting, transforming, and modifying facial, aesthetics, and consulting patients regarding the same
US11400037B2 (en) 2017-03-10 2022-08-02 Johnson & Johnson Consumer Inc. Composition having reduced residue
GB201807576D0 (en) 2018-05-09 2018-06-20 Skinbiotherapeutics Plc Compositions and uses thereof
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
EP3685669A1 (en) * 2019-01-23 2020-07-29 Chrisal NV Composition for the decontamination and inoculation of surfaces
CA3156574A1 (en) * 2019-11-26 2021-09-30 Quorum Innovations, Llc Novel protective barrier compositions, and uses thereof
IL297385A (en) * 2020-05-06 2022-12-01 Quorum Innovations Llc A new protein, and its therapeutic and cosmetic uses
KR102167387B1 (ko) 2020-05-14 2020-10-19 코스맥스 주식회사 피부 장벽 강화, 피부 보습 또는 항노화를 위한 조성물
CN116133669A (zh) * 2020-06-06 2023-05-16 群体创新有限责任公司 用于抑制包括冠状病毒感染的病毒感染的材料和方法
WO2022069379A1 (en) * 2020-09-29 2022-04-07 Unilever Ip Holdings B.V. A personal care composition comprising amino acids
KR102573754B1 (ko) * 2021-02-25 2023-09-01 주식회사 차메디텍 신규의 펩타이드 및 이를 포함하는 피부장벽 강화 또는 피부가려움증 억제를 위한 화장료 조성물
KR102389749B1 (ko) * 2021-05-14 2022-04-22 주식회사 세바바이오텍 피부장벽강화 및 항주름 활성을 갖는 피부 유래 락토바실러스 퍼멘텀 아종 세바­１０１ 균주 및 이의 용도
CN113832050B (zh) * 2021-08-13 2022-10-21 广东省科学院微生物研究所(广东省微生物分析检测中心) 一株高效合成烟酰胺、抗光老化的发酵乳杆菌xjc60及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS057102A0 (en) * 2002-02-15 2002-03-07 Vri Biomedical Ltd Compositions and methods for treatment of skin disorders
US20050014729A1 (en) * 2003-07-16 2005-01-20 Pharmacia Corporation Method for the treatment or prevention of dermatological disorders with a cyclooxygenase-2 inhibitor alone and in combination with a dermatological treatment agent and compositions therewith
EP1736537A1 (en) * 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
JP2007284360A (ja) * 2006-04-13 2007-11-01 Mitsukan Group Honsha:Kk 乳酸菌由来のｐｐａｒ依存的遺伝子転写活性化組成物
RU2009125184A (ru) * 2006-12-01 2011-01-10 Органобэлэнс Гмбх (De) Композиции, наборы и их применения для защиты кожи от патогенных микроорганизмов
US9113641B2 (en) * 2007-12-06 2015-08-25 Arla Foods Amba Probiotic bacteria and regulation of fat storage
CZ2009724A3 (cs) * 2009-11-04 2011-02-09 Bio Agens Research And Development - Bard, S.R.O. Protiplísnová smes s houbovým organismem Pythium oligandrum
SG184901A1 (en) * 2010-04-16 2012-11-29 Davos Life Science Pte Ltd Synergistic interaction of at least one vitamin e component and tyrosinase inhibitors for dermatological applications
US9220672B2 (en) * 2011-02-09 2015-12-29 Organobalance Gmbh Peptide for use in the treatment of skin conditions
CN111518866A (zh) 2011-03-01 2020-08-11 群体创新有限责任公司 用于治疗与致病生物膜相关之病症的材料和方法
CN102226157B (zh) * 2011-05-06 2013-01-09 北京龙科方舟生物工程技术有限公司 一株发酵乳杆菌及其应用
MY172363A (en) 2011-12-07 2019-11-21 Asahi Group Holdings Ltd Lipid metabolism and/or sugar metabolism improver containing lactic acid bacterium or treatment product thereof
EP3324986B1 (en) * 2015-07-20 2021-11-24 Quorum Innovations, LLC Materials and methods for improving immune responses and the skin and/or mucosal barrier function

Also Published As

Publication number Publication date
US20230165915A1 (en) 2023-06-01
US20200215130A1 (en) 2020-07-09
IL256973A (en) 2018-03-29
EP3324986B1 (en) 2021-11-24
ES2904555T3 (es) 2022-04-05
BR112018001187A2 (pt) 2018-09-11
EP3324986A4 (en) 2019-01-09
WO2017015275A1 (en) 2017-01-26
US20170296599A1 (en) 2017-10-19
EP3324986A1 (en) 2018-05-30
CN108135947B (zh) 2022-06-14
PL3324986T3 (pl) 2022-04-04
AU2016297539B9 (en) 2019-11-28
US20170224748A1 (en) 2017-08-10
MX2018000870A (es) 2018-05-15
US10617726B2 (en) 2020-04-14
HK1253067A1 (zh) 2019-06-06
BR112018001187B1 (pt) 2022-02-15
US10004772B2 (en) 2018-06-26
JP6727285B2 (ja) 2020-07-22
ZA201800209B (en) 2018-12-19
DK3324986T3 (da) 2022-01-31
CA2991990A1 (en) 2017-01-26
KR20180023012A (ko) 2018-03-06
US9706778B2 (en) 2017-07-18
CN108135947A (zh) 2018-06-08
JP2018527322A (ja) 2018-09-20
US11564957B2 (en) 2023-01-31
KR102258415B1 (ko) 2021-05-28
US20170020139A1 (en) 2017-01-26
AU2016297539B2 (en) 2019-10-31
AU2016297539A1 (en) 2018-02-08
PT3324986T (pt) 2022-01-26
IL256973B (en) 2020-06-30
CA2991990C (en) 2024-04-16

Similar Documents

Publication Publication Date Title
HK1253067A1 (zh) 提高免疫應答和皮膚和/或粘膜屏障功能的材料和方法
HK1243104A1 (zh) 抗fgfr2/3抗體及其使用方法
GB201508074D0 (en) People detection
ZA201805805B (en) Formulations and methods
IL261140B (en) Antibodies against tnf-alpha and functional fragments thereof
EP3129402A4 (en) Site-specific antibody-drug glycoconjugates and methods
ZA202108600B (en) Anti-tnfalpha-antibodies and functional fragments thereof
GB201411913D0 (en) Cosmetic methods and products
GB201521318D0 (en) Motorised karts
GB201710288D0 (en) Products and methods
ZA201802483B (en) Mouthwash products and methods
IL261261A (en) Antibodies against tnf-alpha and functional fragments thereof
GB201416293D0 (en) Methods and preparations
GB201608776D0 (en) Methods and compounds
PT3458509T (pt) Produtos de alumina e uso dos mesmos em composições de polímero com alta condutividade térmica
IL261098A (en) Antibodies against tnf-alpha and functional fragments thereof
IL261793A (en) Anti-tnfalpha antibodies and their functional parts
GB201517786D0 (en) Methods and materials
PL3438050T3 (pl) Biały materiał pochłaniający promieniowanie w bliskiej podczerwieni oraz sposób jego wytwarzania
GB201610647D0 (en) Improved sensor and associated methods
GB201603227D0 (en) Utensil and method
GB201508028D0 (en) Sandfalls and the like
GB201409033D0 (en) An innovative and improved wind-proof fence
GB201616489D0 (en) Solid products and their use
GB201522978D0 (en) The cholesteral-lowering composite and its preparation method